| Followers | 375 |
| Posts | 16984 |
| Boards Moderated | 4 |
| Alias Born | 03/07/2014 |
Sunday, February 08, 2015 11:54:07 AM
Quote:
"Quote: "No matter how you spin it, you can't deny the straight fact that Bioheart is spending almost nothing on R&D (aka trials) qtr over qtr while their general and admin costs/expenses have increased qtr over qte, and more so than ever in their recent history."
Disagree"
Disagreeing with SEC filings? Disagreeing with the company's own 10-Q filed reality and SEC documents and published financial statements? That's pretty funny to me.
From BHRT last filed SEC 10-Q, PAGE 5 (disagree with it I guess? But it's reality in numbers- and they don't lie)
There it is in living color- huge CUTS to R&D spending, bringing total R&D spending to less than $3K a month for the entire qtr. MASSIVE increases in general and admin expenses (almost a double yr over yr) and a very large loss from operations, an increase in loss from operations, yr over yr. "disagree" with it I guess? It's right there in their own SEC filing?
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
